Hepion Pharmaceuticals Inc (HEPA):企業の財務・戦略的SWOT分析

◆英語タイトル:Hepion Pharmaceuticals Inc (HEPA) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH503409FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Hepion Pharmaceuticals Inc (Hepion) formerly known as ContraVir Pharmaceuticals Inc, is a biopharmaceutical company that offers development and commercialization of targeted antiviral therapies. The company provides pipeline product such as TXL, potent prodrug of antiviral tenofovir and CRV431 cyclophilin inhibitor that increases its potency and selective index against HBV. It products are used for the treatment of chronic hepatitis B and shingles. Hepion serves atients and healthcare professionals by developing differentiated therapeutic products. The company operates in the US. Hepion is headquartered in Edison, New Jersey, the US.

Hepion Pharmaceuticals Inc Key Recent Developments

Mar 22,2021: Hepion Pharmaceuticals Announces Presentation and Panel Participation at the Benzinga Global Biotech Small Cap Conference
Oct 05,2020: Hepion Pharmaceuticals introduces proprietary A.I. platform for drug development & announces creation of clinical pharmacology analytics team
Jun 10,2020: Hepion Pharmaceuticals welcomes industry veteran and drug development expert, Dr. Peter Wijngaard, to its Board of Directors
Apr 13,2020: Hepion Pharmaceuticals receives loan under Paycheck Protection Program

This comprehensive SWOT profile of Hepion Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Hepion Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Hepion Pharmaceuticals Inc – Key Information
Hepion Pharmaceuticals Inc – Overview
Hepion Pharmaceuticals Inc – Key Employees
Hepion Pharmaceuticals Inc – Key Employee Biographies
Hepion Pharmaceuticals Inc – Key Operational Heads
Hepion Pharmaceuticals Inc – Major Products and Services
Hepion Pharmaceuticals Inc – History
Hepion Pharmaceuticals Inc – Company Statement
Hepion Pharmaceuticals Inc – Locations And Subsidiaries
Hepion Pharmaceuticals Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Hepion Pharmaceuticals Inc – Business Description
Hepion Pharmaceuticals Inc – Corporate Strategy
Hepion Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Hepion Pharmaceuticals Inc – Strengths
Hepion Pharmaceuticals Inc – Weaknesses
Hepion Pharmaceuticals Inc – Opportunities
Hepion Pharmaceuticals Inc – Threats
Hepion Pharmaceuticals Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Hepion Pharmaceuticals Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Hepion Pharmaceuticals Inc, Key Information
Hepion Pharmaceuticals Inc, Key Ratios
Hepion Pharmaceuticals Inc, Share Data
Hepion Pharmaceuticals Inc, Major Products and Services
Hepion Pharmaceuticals Inc, History
Hepion Pharmaceuticals Inc, Key Employees
Hepion Pharmaceuticals Inc, Key Employee Biographies
Hepion Pharmaceuticals Inc, Key Operational Heads
Hepion Pharmaceuticals Inc, Other Locations
Hepion Pharmaceuticals Inc, Subsidiaries
Hepion Pharmaceuticals Inc, Key Competitors
Hepion Pharmaceuticals Inc, SWOT Analysis
Hepion Pharmaceuticals Inc, Ratios based on current share price
Hepion Pharmaceuticals Inc, Annual Ratios
Hepion Pharmaceuticals Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Hepion Pharmaceuticals Inc (HEPA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • InMed Pharmaceuticals Inc (IN):医療機器:M&Aディール及び事業提携情報
    Summary InMed Pharmaceuticals Inc (InMed), formerly Cannabis Technologies Inc, is a pre-clinical stage biopharmaceutical company which develops, produces and markets plant cannabinoid based medicines. The company's pipeline products include INM-750, INM-405, and INM-085. Its products finds applicati …
  • Diamond Offshore Drilling Inc (DO)-石油・ガス分野:企業M&A・提携分析
    Summary Diamond Offshore Drilling, Inc. (Diamond Offshore) is an offshore oil and gas drilling company, which provides contract drilling services to the energy industry. It operates through a fleet of offshore drilling rigs comprising semisubmersibles, jack-ups, and dynamically positioned drillships …
  • LGT Group Foundation:企業の戦略・SWOT・財務情報
    LGT Group Foundation - Strategy, SWOT and Corporate Finance Report Summary LGT Group Foundation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Clean Harbors, Inc. (CLH):企業の財務・戦略的SWOT分析
    Clean Harbors, Inc. (CLH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Richter Gedeon Nyrt (RICHTER):製薬・医療:M&Aディール及び事業提携情報
    Summary Richter Gedeon Nyrt (Richter) is a pharmaceutical company that develops, manufactures and commercializes a wide range of drugs including original, generic and licensed products and over-the-counter (OTC) medicines. The company’s product portfolio encompasses medicines to treat gynaecological …
  • MOIL Limited:企業の戦略・SWOT・財務情報
    MOIL Limited - Strategy, SWOT and Corporate Finance Report Summary MOIL Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • East Japan Railway Company:企業の戦略・SWOT・財務情報
    East Japan Railway Company - Strategy, SWOT and Corporate Finance Report Summary East Japan Railway Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • New York Independent System Operator Inc:企業の戦略的SWOT分析
    New York Independent System Operator Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Holidaybreak Ltd:企業の戦略・SWOT・財務情報
    Holidaybreak Ltd - Strategy, SWOT and Corporate Finance Report Summary Holidaybreak Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Emirates NBD Bank:企業の戦略・SWOT・財務分析
    Emirates NBD Bank - Strategy, SWOT and Corporate Finance Report Summary Emirates NBD Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Federal Grid Company of Unified Energy System (FEES):企業の財務・戦略的SWOT分析
    Federal Grid Company of Unified Energy System (FEES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s k …
  • PT Jasa Marga (Persero) Tbk:企業の戦略・SWOT・財務情報
    PT Jasa Marga (Persero) Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Jasa Marga (Persero) Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • ProThera Biologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary ProThera Biologics Inc (ProThera), formerly ProThera Biologics LLC is a biotherapeutics company that develops novel products based on Inter-alpha Inhibitor Proteins. The company offers development of commercial potential of IAIP for treating acute, life-threatening inflammatory diseases. Pro …
  • London North West Healthcare NHS Trust:企業の戦略的SWOT分析
    London North West Healthcare NHS Trust - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • American Bio Medica Corp (ABMC):企業の財務・戦略的SWOT分析
    Summary American Bio Medica Corp (ABMC) is a biotechnology company that develops, manufactures and markets immunoassay test kits. The company’s products include Rapid TOX, a point of collection testing product that detects 1-10 drugs of abuse in a urine specimen; Rapid One, a test cassette which is …
  • Gas Natural Fenosa:企業のM&A・事業提携・投資動向
    Gas Natural Fenosa - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Gas Natural Fenosa Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Encompass Digital Media, Inc.:企業の戦略・SWOT・財務情報
    Encompass Digital Media, Inc. - Strategy, SWOT and Corporate Finance Report Summary Encompass Digital Media, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Hollard Insurance Group:企業の戦略・SWOT・財務情報
    Hollard Insurance Group - Strategy, SWOT and Corporate Finance Report Summary Hollard Insurance Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Tatung Co. Ltd. (2371):企業の財務・戦略的SWOT分析
    Summary Tatung Co. Ltd. (Tatung) is an electronic product manufacturer that designs, manufactures, distributes and sells digital consumer products. The company operates through its business group such as power, consumer and system solution group. Its power business group provides transformers, switc …
  • Suven Life Sciences Ltd (SUVEN):企業の財務・戦略的SWOT分析
    Summary Suven Life Sciences Ltd (Suven) formerly Suven Pharmaceuticals Pvt Ltd designs, develops, manufactures and supplies bulk actives, drug intermediates and fine chemicals. The company offers active pharmaceutical ingredient products which include aripiprazole, calcium acetate, divalproex sodium …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆